Publications | Lund University Publications

81 – 90 of 188

show: 10
|
sort: year (new to old)

News feed Embed this list Save this search Mark all Export

Cancel

Embed this list

copy and paste the html snippet below into your own page:

<iframe src="https://lup.lub.lu.se/search/publication?embed=1&q=author+exact+%22af7e247a-381e-4a1c-a1d8-7625b1488a9e%22&amp;hide_pagination=1&amp;hide_info=1&amp;hide_options=1"
  width="100%"
  height="400"
  allowtransparency="true"
  frameborder="0">
</iframe>

« previous
1
…
8
9
10
11
…
19
next »

2013
Mark Factor VIII gene (F8) mutation and risk of inhibitor development in nonsevere hemophilia A
Eckhardt, Corien L. ; van Velzen, Alice S. ; Peters, Marjolein ; Astermark, Jan ^LU ; Brons, Paul P. ; Castaman, Giancarlo ; Cnossen, Marjon H. ; Dors, Natasja ; Escuriola-Ettingshausen, Carmen and Hamulyak, Karly , et al. (2013) In Blood 122(11). p.1954-1962
- Contribution to journal › Article
Mark Incidence, mortality rates and causes of deaths in haemophilia patients in Sweden.
Lövdahl, Susanna ^LU ; Henriksson, Marie ^LU ; Baghaei, F ; Holmström, Eva M ^LU ; Nilsson, J-Å ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2013) In Haemophilia 19(3). p.362-369
- Contribution to journal › Article
Mark F8 haplotype and inhibitor risk: results from the Hemophilia Inhibitor Genetics Study (HIGS) Combined Cohort
Schwarz, J. ; Astermark, Jan ^LU ; Menius, E. D. ; Carrington, M. ; Donfield, S. M. ; Gomperts, E. D. ; Nelson, G. W. ; Oldenburg, J. ; Pavlova, A. and Shapiro, A. D. , et al. (2013) In Haemophilia 19(1). p.113-118
- Contribution to journal › Article
2012
Mark F8 gene mutation type and inhibitor development in patients with severe hemophilia A: systematic review and meta-analysis
Gouw, Samantha C. ; van den Berg, H. Marijke ; Oldenburg, Johannes ; Astermark, Jan ^LU ; de Groot, Philip G. ; Margaglione, Maurizio ; Thompson, Arthur R. ; van Heerde, Waander ; Boekhorst, Jorien and Miller, Connie H. , et al. (2012) In Blood 119(12). p.2922-2934
- Contribution to journal › Scientific review
Mark Exposure to factor VIII and prediction of inhibitor development: exposure days vs. danger days, or both?
Hermans, C. ; Astermark, Jan ^LU and De Moerloos, P. (2012) In Journal of Thrombosis and Haemostasis 10(10). p.2194-2196
- Contribution to journal › Letter
Mark Treatment of haemophilia A and B and von Willebrand's disease: summary and conclusions of a systematic review as part of a Swedish health-technology assessment.
Berntorp, Erik ^LU ; Astermark, Jan ^LU ; Baghaei, F ; Bergqvist, D ; Holmström, M ; Ljungberg, Bengt ^LU ; Norlund, A ; Palmblad, J ; Petrini, A and Stigendal, L , et al. (2012) In Haemophilia 18(2). p.158-165
- Contribution to journal › Article
Mark Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
Klintman, Jenny ^LU ; Hillarp, Andreas ^LU ; Donfield, S ; Berntorp, Erik ^LU and Astermark, Jan ^LU (2012) In Haemophilia
- Contribution to journal › Article
Mark The Arosenius Fund.
Astermark, Jan ^LU (2012) In Haemophilia 18. p.41462-41462
- Contribution to journal › Article
Mark Daily dosing prophylaxis for haemophilia: a randomized crossover pilot study evaluating feasibility and efficacy.
Lindvall, Karin ^LU ; Astermark, Jan ^LU ; Björkman, S ; Ljung, R ; Carlsson, K S ; Persson, S and Berntorp, Erik ^LU (2012) In Haemophilia 18(6). p.855-859
- Contribution to journal › Article
Mark Lifelong prophylaxis in a large cohort of adult patients with severe haemophilia: a beneficial effect on orthopaedic outcome and quality of life.
Khawaji, Mohammed ^LU ; Astermark, Jan ^LU and Berntorp, Erik ^LU (2012) In European Journal of Haematology 88(4). p.329-335
- Contribution to journal › Article

« previous
1
…
8
9
10
11
…
19
next »

your query:: Remove author: Astermark, Jan (LU)